Neuropeptide Y as a Marker in Pediatric Neuroblastoma

References

• Allen J M, Bloom S R. Neuropeptide Y: A putative neurotransmitter. Neurochem Int 1986; 8: 1–8
   PubMed Web of Science ®Google Scholar
• Potter E K. Neuropeptide Y as an autonomic neurotransmitter. Pharmacol Ther 1988; 37: 251–73
   PubMed Web of Science ®Google Scholar
• Tatemoto K. Neuropeptide Y: Complete amino acid sequence of the brain peptide. Proc Natl Acad Sci USA 1982; 79: 5485–9
   PubMed Web of Science ®Google Scholar
• Lundberg J M, Martinsson A, Hemsen A, et al. Co-release of neuropeptide Y and catecholamines during physical exercise in man. Biochem Biophys Res Commun 1985; 133: 30–6
   PubMed Web of Science ®Google Scholar
• Lundberg J M, Fried G, Pernow J, Theodorsson-Norheim E, Änggard A. NPY—A mediator of reserpine resistant, nonadrenergic vasoconstriction in cat spleen after preganglionic denervation?. Acta Physiol Scand 1986; 126: 151–2
   PubMedGoogle Scholar
• Takahashi K, Mouri T, Murakami O, et al. Increases of neuropeptide Y-like immunoreactivity in plasma during insulin-induced hypoglycemia in man. Peptides 1988; 9: 433–5
   PubMedGoogle Scholar
• Lundberg J M, Hemsen A, Fried G, Theodorsson-Norheim E, Lagercrantz H. Co-release of neuropeptide Y (NPY)-like immunoreactivity and catecholamines in newborn infants. Acta Physiol Scand 1986; 126: 471–3
   PubMedGoogle Scholar
• Adrian T E, Allen J M, Terenghi G, et al. Neuropeptide Y in phaeochromocytomas and ganglioneuroblastomas. Lancet 1983; 2: 540–2
   PubMedGoogle Scholar
• Corder R, Emson P C, Lowry P J. Purification and characterization of human neuropeptide Y from adrenal-medullary phaeochromocytoma tissue. Biochem J 1984; 219: 699–706
   PubMedGoogle Scholar
• Lundberg J M, Hökfelt T, Hemsen A, et al. Neuropeptide Y-like immunoreactivity in adrenaline cells of adrenal medulla and in tumors and plasma of pheochromocytoma patients. Regul Pept 1986; 13: 169–82
   PubMedGoogle Scholar
• Allen J M, Yeats J C, Causon R, Brown M J, Bloom S R. Neuropeptide Y and its flanking peptide in human endocrine tumors and plasma. J Clin Endocrinol Metab 1987; 64: 1199–204
   PubMedGoogle Scholar
• Tischler A S, Allen J M, Costopoulos D, Bloom S R. Increased content of neuropeptide Y in human pheochromocytoma cell cultures. J Clin Endocrinol Metab 1985; 61: 303–5
   PubMedGoogle Scholar
• Connell J M, Corder R, Asbury J, et al. Neuropeptide Y in multiple endocrine neoplasia: Release during surgery for phaeochromocytoma. Clin Endocrinol 1987; 26: 75–84
   PubMed Web of Science ®Google Scholar
• Minth C D, Bloom S R, Polak J M, Dixon J E. Cloning, characterization and DNA sequence of a human cDNA encoding neuropeptide tyrosine. Proc Natl Acad Sci USA 1984; 81: 4577–81
   PubMedGoogle Scholar
• Takeuchi T, Gumucio D L, Yamada T, et al. Genes encoding pancreatic polypeptide and neuropeptide Y are on human chromosomes 17 and 7. J Clin Invest 1986; 77: 1038–41
   PubMedGoogle Scholar
• Minth C D, Andrews P C, Dixon J E. Characterization, sequence, and expression of the cloned human neuropeptide Y gene. J Biol Chem 1986; 261: 11974–79
   PubMedGoogle Scholar
• Helman L J, Averbusch S D, Cohen P S, Keiser H R, Israel M A. Patterns of neuropeptide Y (NPY) expression in pheochromocytoma (Ph) may define biologically distinct subgroups. (Abstact). Proc Am Assoc Cancer Res 1988; 29: 441, (A1752)
   Google Scholar
• International Incidence of Childhood Cancer, D M Parkin, C A Stiller, G J Draper, C A Bieber, B Terracini, J L Young. IARC Scientific Publications No. 87, International Agency for Research on Cancer, Lyon 1988
   Google Scholar
• Hammond G D. The cure of childhood cancers. Cancer 1986; 58(Suppl 2)407–13
   PubMedGoogle Scholar
• Pritchard J, Kiely E, Rogers D W, et al. Long-term survival after advanced neuroblastoma. (Letter). N Engl J Med 1987; 317: 1026–7
   PubMed Web of Science ®Google Scholar
• Gitlow S E, Dziedzic L B, Dziedzic S W. Catecholamine metabolism in neuroblastoma. Neuroblastoma, C Pochedly. Edward Arnold, London 1977
   Google Scholar
• Tuchman M, Ramnaraine M L, Woods W G, Krivit W. Three years of experience with random urinary homovanillic and vanillylmandelic acid levels in the diagnosis of neuroblastoma. Pediatrics 1987; 79: 203–5
   PubMedGoogle Scholar
• Theodorsson-Norheim E, Hemsen A, Lundberg J M. Radioimmunoassay for neuropeptide Y (NPY): Chromatographic characterization of immunoreactivity in plasma and tissue extracts. Scand J Clin Lab Invest 1985; 45: 355–65
   PubMed Web of Science ®Google Scholar
• Molnar I, Horvath C. Reverse-phase chromatography of polar biological substances: Separation of catechol compounds by high-performance liquid chromatography. Clin Chem 1976; 22: 1497–502
   PubMed Web of Science ®Google Scholar
• Shackleton C H L, Whitney J O. Use of Sep-pak cartridges for urinary steroid extraction: Evaluation of the method for use prior to gas chromatographic analysis. Clin Chim Acta 1980; 107: 231–43
   PubMed Web of Science ®Google Scholar
• Riggin R M, Kissinger P T. Determination of catecholamines in urine by reverse-phase liquid chromatography with electrochemical detection. (Letter). Anal Chem 1977; 49: 2109–11
   PubMed Web of Science ®Google Scholar
• Moyer T P, Jiang N S, Tyce G M, Sheps S G. Analysis for urinary catecholamines by liquid chromatography with amperometric detection: Methodology and clinical interpretation of results. Clin Chem 1979; 25: 256–63
   PubMed Web of Science ®Google Scholar
• Pisano J J, Crout J R, Abraham D. Determination of 3–methoxy-4–hydroxymandelic acid in urine. Clin Chim Acta 1962; 7: 285–91
   PubMed Web of Science ®Google Scholar
• Theodorsson-Norheim E. Kruskal-Wallis test: BASIC computer program to perform nonparametric one-way analysis of variance and multiple comparisons on rank of several independent samples. Comput Methods Programs Biomed 1986; 23: 57–62
   PubMed Web of Science ®Google Scholar
• Evans A E, D'Angio G J, Randolph J. A proposed staging for children with neuroblastoma. Children's Cancer Study Group A. Cancer 1971; 27: 374–8
   PubMed Web of Science ®Google Scholar
• Brodeur G M, Seeger R C, Barrett A, et al. International criteria for diagnosis, staging and response to treatment in patients with neuroblastoma. J Clin Oncol 1988; 6: 1874–81
   PubMed Web of Science ®Google Scholar
• Triche T J, Askin F B, Kissane J M. Neuroblastoma, Ewing's sarcoma, and the differential diagnosis of small-, round-, blue-cell tumors. Pathology of Neoplasia in Children and Adolescents, M J Finegold. WB Saunders, Philadelphia 1986; 145–95, (Major Problems in Pathology, vol 18)
   Google Scholar
• Pernow J, Lundberg J M, Kaijser L. Vasoconstrictor effects in vivo and plasma disappearance rate of neuropeptide Y in man. Life Sci 1987; 40: 47–54
   PubMed Web of Science ®Google Scholar
• Pernow J, Lundberg J M, Kaijser L. Alpha-adrenoceptor influence on plasma levels of neuropeptide Y-like immunoreactivity and catecholamines during rest and sympatho-adrenal activation in humans. J Cardiovasc Pharmacol. 1988; 12: 593–9
   PubMed Web of Science ®Google Scholar
• Brodeur G M, Seeger R C, Schwab M, Varmus H E, Bishop J M. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science 1984; 224: 1121–4
   PubMed Web of Science ®Google Scholar
• Seeger R C, Brodeur G M, Sather H, et al. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. New Engl J Med 1985; 313: 1111–6
   PubMed Web of Science ®Google Scholar
• Allen J M, Martin J B, Heinrich G. Neuropeptide Y gene expression in PC12 cells and its regulation by nerve growth factor: A model for developmental regulation. Mol Brain Res 1987; 3: 39–43
   Google Scholar
• Mirkin B L, Fink D W, Jr, O'Dea R F. “In situ” modulation of murine neuroblastoma growth and biochemical differentiation by the adrenergic nervous system and nerve growth factor. Prog Clin Biol Res 1988; 271: 317–26
   PubMedGoogle Scholar
• Tischler A S, Slayton V, Costopoules D S, Leape L L, DeLellis R A, Wolfe H J. Nerve growth factor may function as a survival factor for human neuroblastoma cells in culture. Cancer 1984; 54: 1344–7
   PubMedGoogle Scholar
• Cohen P S, Helman L J, Seeger R C, Israel M A. Neuropeptide Y (NPY) expression marks the developmental arrest of stage IV-S neuroblastoma-(NB). (Abstract). Proc Am Soc Clin Oncol 1988; 7: A992
   Google Scholar